International Stem Cell Corp (OTCMKTS:ISCO) Claws its Way Back to Over $0.10
International Stem Cell Corp (OTCMKTS:ISCO) announced yesterday that the FDA has approved their stem cells for investigational clinical uses. A clearance from the regulatory organs is always a positive sign for medical OTC companies...